Related Experiment Video
Updated: Nov 14, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Nucleic Acid Immunotherapeutics for Cancer
Tingting Shen1, Yu Zhang2, Shurong Zhou3
1Molecular Sciences and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering and College of Biology, Collaborative Innovation Center for Molecular Engineering and Theranostics, Hunan University, Changsha 410082, China; Department of Pharmaceutics, Center for Pharmaceutical Engineering and Sciences-School of Pharmacy; Massey Cancer Center; Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia 23298, United States.
Nucleic acid therapeutics, like immunostimulatory DNA/RNA and mRNA, are revolutionizing cancer immunotherapy by harnessing the immune system. These agents require chemical modifications and delivery systems for effective cancer treatment.
Area of Science:
- Biotechnology
- Oncology
- Immunology
Background:
- Nucleic acid therapeutics and cancer immunotherapy have advanced significantly.
- Nucleic acid therapeutics offer unique properties like genetic information storage and immunomodulation.
- Cancer immunotherapy utilizes the patient's immune system, with strategies including immune checkpoint blockade and therapeutic vaccines.
Purpose of the Study:
- To review recent advancements in nucleic acid immunotherapeutics for cancer treatment.
- To highlight the pivotal role of nucleic acid therapeutics in cancer immunotherapy.
- To discuss the characteristics and applications of nucleic acid-based cancer immunotherapies.
Main Methods:
- Review of recent literature on nucleic acid therapeutics and cancer immunotherapy.
- Analysis of different types of nucleic acid immunotherapeutics (e.g., immunostimulatory DNA/RNA, mRNA, plasmids, genome-editing nucleic acids).
- Discussion of chemical modifications and drug delivery systems for nucleic acid therapeutics.
Main Results:
- Nucleic acid therapeutics are emerging as a key class of cancer immunotherapeutics.
- Examples include immunostimulatory nucleic acids and mRNA/plasmids encoding immunotherapeutic proteins.
- Chemical modifications and targeted delivery systems are crucial for therapeutic efficacy.
Conclusions:
- Nucleic acid therapeutics represent a promising frontier in cancer immunotherapy.
- Further research into modifications and delivery is essential for optimizing these treatments.
- The integration of nucleic acid technology offers novel strategies for cancer treatment.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer

